{"id":18956,"date":"2012-01-31T07:06:07","date_gmt":"2012-01-31T12:06:07","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=18956"},"modified":"2012-01-31T07:25:00","modified_gmt":"2012-01-31T12:25:00","slug":"plan-for-the-future","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/01\/31\/plan-for-the-future\/","title":{"rendered":"for the future&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\"><u><strong><a href=\"http:\/\/www.nimh.nih.gov\/about\/director\/2012\/balancing-immediate-needs-with-future-innovation.shtml\" target=\"_blank\"><font color=\"#200020\">Balancing Immediate Needs with Future Innovation<\/font><\/a><\/strong><\/u><br \/>     <strong><font color=\"#200020\">NIMH Director&rsquo;s Blog<\/font><\/strong><br \/>     by Thomas Insel<br \/>     January 26, 2012 <\/div>\n<p><\/p>\n<div align=\"justify\"><sup>NIMH, like all Institutes at NIH, has an advisory council that meets three times each year. The National Advisory Mental Health Council [NAMHC]  is a distinguished group of scientists, advocates, clinicians, and  policy experts. Each of our meetings includes a closed session to review  individual grants considered for funding and a session open to the  public that engages this diverse group in discussions about the larger  issues that guide NIMH funding.<\/p>\n<p> At last week&rsquo;s session, we heard a  recurrent tension around one such larger issue. Some members of Council  bear witness to the poor quality of care, the unmet medical need, and  the diminishing investments by states on behalf of people with mental  disorders. They reasonably ask, &ldquo;<strong><font color=\"#990000\">How are we ensuring that the science  that NIMH has produced is implemented where the need is greatest?<\/font><\/strong>&rdquo; <font color=\"#990000\"><strong>They  also question on the pay-off of genetics research.<\/strong><\/font> After all, two  decades after the gene for Huntington&rsquo;s disease was identified, we still  have no effective treatments, and Huntington&rsquo;s disease is genetically  far simpler than schizophrenia or bipolar disorder. In contrast to so  many neurological diseases, we have effective treatments for  schizophrenia and bipolar disorder. NIMH should be investing to ensure  these are available.<\/p>\n<p> The opposing argument runs something like  this. <strong><font color=\"#990000\">There has been no major innovation in therapeutics for most mental  disorders since 1960.<\/font><\/strong> Current treatments are not good enough for too  many. Rather than investing scarce dollars for incremental improvements  or increased dissemination of mediocre interventions, we need invest in  the fundamental science of brain and behavior so that we can understand  how to develop better treatments.<\/p>\n<p> While I may have oversimplified  the two sides of this debate, the divide is substantial. Some advisors  want more funds in services research; other advisors want more funds in  basic neuroscience. Some are thinking of the immediate needs; others are  focused on the paradigm shifts that may be revealed by another decade  of research. And with the NIMH budget stretched, tough choices must be  made&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">Wasn&#8217;t he the guy that said this in 2005? Here we are having mastered the technology of <em>clinical genomics<\/em> and halfway up the ladder of <em>neuroimaging<\/em> &#8211; on the threshold of <em>biodiagnostics and treatment of core pathology<\/em>. How can we stop now?<\/div>\n<div align=\"center\"><img loading=\"lazy\" decoding=\"async\" height=\"306\" border=\"0\" width=\"400\" vspace=\"5\" src=\"http:\/\/1boringoldman.com\/images\/insel-1.gif\" \/><\/div>\n<div align=\"justify\">Future Innovation? New Director&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Balancing Immediate Needs with Future Innovation NIMH Director&rsquo;s Blog by Thomas Insel January 26, 2012 NIMH, like all Institutes at NIH, has an advisory council that meets three times each year. The National Advisory Mental Health Council [NAMHC] is a distinguished group of scientists, advocates, clinicians, and policy experts. Each of our meetings includes a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-18956","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=18956"}],"version-history":[{"count":11,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18956\/revisions"}],"predecessor-version":[{"id":18967,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18956\/revisions\/18967"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=18956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=18956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=18956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}